Winnipeg firm Regenetek issues statement explaining role in MS study
Thursday, January 15, 2015 - 21:50
in Health & Medicine
A Winnipeg-based company says it stands behind its role in a study involving an experimental treatment for multiple sclerosis, while at least three patients in Canada have brought concerns about the company's CEO to the RCMP.